Resume Gene Cutler, PhD

My goal is to extract biological stories from big data. I have extensive experience in drug development across a range of therapeutic areas from discovery to the clinic. Having been trained as a molecular biologist but with extensive experience in programming and machine learning, I know which questions to ask and which results are meaningful.

Career History

RAPT Therapeutics (formerly FLX Bio)
2018 to 2021 | Senior Director

Computational Biology | Quantitative Biology
Continue to apply Big Data to accelerate drug discovery, including Clinical Trial Biomarker Strategy and Analysis

FLX Bio
2015 to 2018 | Director

Computational Biology | Quantitative Biology
Created FLX Bio’s Computational Biology Group, applying Big Data to all stages of drug discovery from Target ID to Patient Selection Strategies and Clinical Biomarker Planning

Amgen
2011 to 2015 | Scientific Director

Genome Analysis Unit | Discovery Research
Co-lead of the Omics/Computational Biology Group for the Amgen Discovery organization

Amgen
2002 to 2011 | Principal Scientist

Computational Biology | Therapeutic Discovery
Focused on Discovery in Metabolic Disease and Oncology

Tularik
2000 to 2002 | Scientist

Computational Biology | Biology

Tularik
1998 to 2000 | Postdoctoral Fellow

Metabolic Disease | Biology

University of California, Berkeley
1998 | Postdoctoral Fellow

Lab of Dr. Robert Tjian | Molecular & Cell Biology

Education

University of California, Berkeley

1992-1997 | PhD, Molecular and Cell Biology
Lab of Dr. Robert Tjian

Cornell University

1988-1992 | BA, College of Arts and Sciences
Biology Major

Journal Publications

Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4
L Marshall, S Marubayashi, A Jorapur, A Jacobson, M Zibinsky, O Robles, D Hu, J Jackson, D Pookot, J Sanchez, M Brovarney, A Wadsworth, D Chian, D Wustrow, P Kassner, Gene Cutler, B Wong, D Brockstedt, O Talay
Journal for Immunotherapy of Cancer | 11/2020

Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity in Vitro and in Vivo
Y Ohol, M Sun, Gene Cutler, P Leger, D Hu, B Biannic, P Rana, C Cho, S Jacobson, S Wong, J Sanchez, N Shah, D Pookot, B Abraham, K Young, S Suthram, L Marshall, D Bradford, N Kozon, X Han, A Okano, J Maung, C Colas, J Schwarz, D Wustrow, D Brockstedt, P Kassner
Molecular Cancer Therapeutics | 10/2020

Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors
O Robles, J Jackson, L Marshall, O Talay, D Chian, G Cutler, R Diokno, D Hu, S Jacobson, E Karbarz, P Kassner, J Ketcham, J McKinnell, C Meleza, M Reilly, E Riegler, H Shunatona, A Wadsworth, A Younai, D Brockstedt, D Wustrow, M Zibinsky
Journal of Medicinal Chemistry | 7/2020

Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4
L Marshall, S Marubayashi, A Jorapur, A Jacobson, M Zibinsky, O Robles, Dennis X Hu, J Jackson, D Pookot, J Sanchez, M Brovarney, A Wadsworth, D Chian, D Wustrow, P Kassner, G Cutler, B Wong, D Brockstedt, O Talay
Journal for Immunotherapy of Cancer | 11/2020

Targeting The Stress Response Kinase GCN2 To Restore Immunity In The Tumor Microenvironment
L Marshall, B Ravishankar, L Adusumilli, M Zibinsky, D Pookot, E Huang, O Talay, S Suthram, J Jackson, G Shibuya, P Leger, P Tivitmahaisoon, A Okal, D Bradford, C Colas, G Cutler, J Schwartz, Wustrow, P Kassner, D Brockstedt
Journal for Immunotherapy of Cancer | 11/2019

Discovery of potent and selective inhibitors of USP7 with anti-tumor activity in vitro and in vivo
Y Ohol, M Sun, G Cutler, P Leger, D Hu, B Biannic, P Rana, C Cho, S Jacobson, S Wong, J Sanchez, X
Han, K Young, A Okano, N Shah, B Abraham, D Pookot, J Maung, D Bradford, N Kozon, S Suthram, L
Adusumilli, D Kaveri, O Talay, C Colas, A Kim, J Schwarz
Cancer Research | 7/2019

Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor
Microenvironment
J Jackson, J Ketcham, A Younai, B Abraham, B Biannic, H Beck, M Bui, D Chian, G Cutler, R Diokno, D
Hu, S Jacobson, E Karbarz, P Kassner, L Marshall, J McKinnell, C Meleza, A Okal, D Pookot, M Reilly, O
Robles, H Shunatona, O Talay, J Walker, A Wadsworth, D Wustrow, M Zibinsky
Journal of Medicinal Chemistry | 6/2019

FLX925 Is a Rationally Designed FLT3, CDK4/6 Inhibitor with a Desirable Resistance Profile
S Marubayashi, A Park, R Noubade, H Phan, G Cutler, P Kassner, JS Fridman
Blood | 12/2016

A Machine-Learning Analysis Suggests That FLX925, a FLT3/CDK4/6 Kinase Inhibitor, Is Potent
Against FLT3-Wild Type Tumors Via Its CDK4/6 Activity
G Cutler, JS Fridman
Blood | 12/2016

Advancing therapeutic discovery through phenotypic screening of the extracellular proteome using
hydrodynamic intravascular injection
H Baribault, JZ Majeti, H Ge, J Wang, Y Xiong, J Gardner, L Yang, J Gupte, Y Gong, Z Pan, G Cutler, PD
Kassner, H Tu, B Shan, X Wu, and Y Li
Expert opinion on therapeutic targets | 11/2014

Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial
signaling pathways
R Blum, R Gupta, PE Burger, CS Ontiveros, SN Salm, X Xiong, A Kamb, H Wesche, L Marshall, G Cutler,
X Wang, J Zavadil, D Moscatelli, EL Wilson
PLoS One | 09/30/2010

Identification of transcriptional networks responding to pyrroloquinoline quinone dietary
supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK
pathways
E Tchaparian, L Marshal, G Cutler, K Bauerly, W Chowanadisai, M Satre, C Harris, RB Rucker
Biochemical Journal | 08/01/2010

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights
into prostate cancer
R Blum, R Gupta, PE Burger, CS Ontiveros, SN Salm, X Xiong, A Kamb, H Wesche, L Marshall, G Cutler,
X Wang, J Zavadil, D Moscatelli, EL Wilson
PloS One | 05/09/2009

Copy number variation in the mouse genome: implications for the mouse as a model organism for human disease
G Cutler, PD Kassner
Cytogenetics and Genome Research | 03/11/2009

Significant gene content variation characterizes the genomes of inbred mouse strains
G Cutler, LA Marshall, N Chin, H Baribault, PD Kassner
Genome Research | 01/12/2007

Impact of diet on hepatic gene expression in response to selected drugs and nutrients
E Tchaparian, K Bauerly, C Harris, M Satre, W Chowanadisai, G Cutler, L Marshall, A Mitchell, R Rucker
FASEB Journal | 03/2007

Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
S Herter, D Piper, W Aaron, T Gabriele, G Cutler, P Cao, A Bhatt, Y Choe, C Craik, N Walker, D Meininger, T Hoey, R Austin
Biochemical Journal | 08/15/2005

Multiclass cancer classification and biomarker discovery using GA-based algorithms
JJ Liu, G Cutler, W Li, Z Pan, S Peng, T Hoey, L Chen, XB Ling
Bioinformatics | 06/01/2005

Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach
J Gupte, G Cutler, JL Chen, H Tian
Proceedings of the National Academy of Sciences | 02/10/2004

A comparative analysis of HGSC and Celera human genome assemblies and gene sets
S Li, G Cutler, JJ Liu, T Hoey, L Chen, PG Schultz, J Liao, XB Ling
Bioinformatics | 09/01/2003

Comparative analysis of human genome assemblies reveals genome-level differences
S Li, J Liao, G Cutler, T Hoey, JB Hogenesch, MP Cooke, PG Schultz, XB Ling
Genomics | 08/31/2002

Identification and characterization of a melanin-concentrating hormone receptor
S An, G Cutler, JJ Zhao, SG Huang, H Tian, W Li, L Liang, M Rich, A Bakleh, J Du, JL Chen, K Dai Proceedings of the National Academy of Sciences | 06/19/2001

Adf-1 is a nonmodular transcription factor that contains a TAF-binding Myb-like motif
G Cutler, KM Perry, R Tjian
Molecular and cellular biology | 04/01/1998

Contacts in context: promoter specificity and macromolecular interactions in transcription
JA Goodrich, G Cutler, R Tjian
Cell | 03/22/1996

Other Media

INTERVIEW
Next Generation Sequencing Roundtable
November 14, 2011

BOOK CHAPTER
Genomic resources for cancer biologists
XB Ling, G Cutler, T Hoey

The Oncogenomics Handbook | Humana Press | 04/15/2005

Select Patents

Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof
B Biannic, X Han, D Hu, P Leger, J Maung, A Okano, J Schwarz, D Wustrow, K Young, Gene Cutler, Y Ohol-Gupta
US Patent 16578276 | 03/26/2020

Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof
KC Quon, G Cutler, JJ Kordich
US Patent 8,735,548 | 05/27/2014

FUSION PROTEINS IN CANCER
KC Quon, G Cutler, JJ Kordich
US Patent 20130095111 | 04/18/2013

SCNN1A/TNFRSF1A FUSION PROTEINS IN CANCER
KC Quon, G Cutler, JJ Kordich
WO Patent 2012012141 | 01/27/2012

NOVEL RECEPTORS
JL Chen, G Cutler, K Dai, H Tian, J Zhao
US Patent 11/680,133 | 02/28/2007

NOVEL RECEPTORS
H Tian, J Zhao, JL Chen, G Cutler
US Patent 11/086,846 | 03/21/2005